×
Back to Agenda
S03 : Open Science accelerated by COVID-19, followed by Evidence Generation in the Era of Artificial Intelligence and Digital Transformation
Session Chair(s)
Tadashi Urashima, PHD
Performance and Digital Analytics Lead, Japan Development, GlaxoSmithKline K.K., Japan
Speaker(s)
Toshibumi Taniguchi, MD, PHD
, Chiba University Hospital, Japan
Behind the Scenes of COVID-19 Clinical Practice Dealing with Emerging Infectious Diseases without Information
Ayano Hata
, Shionogi & Co., Ltd, Japan
Shinsuke Muto
Executive Chairman, Integrity Healthcare Co., Ltd., Japan
Have an account?